+440.9%
FLEX vs MRNA
+27.9%
+412.9%
-40.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | +0.7% | -4.9% | -4.2% |
| 7D | +0.1% | -8.2% | +8.3% | +0.3% |
| 30D | -11.8% | +125.6% | -137.3% | -16.2% |
| 3M | -22.6% | +197.1% | -219.6% | -31.4% |
| 6M | +77.3% | +148.5% | -71.2% | +61.9% |
| YTD | +78.8% | +363.3% | -284.5% | +44.6% |
| 1Y | +86.1% | +462.0% | -375.9% | +44.0% |
| All | +440.9% | +27.9% | +412.9% | +393.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling